Mostrar el registro sencillo del ítem

dc.contributor.author
Ugalde Arbizu, Maider  
dc.contributor.author
Aguilera Correa, John Jairo  
dc.contributor.author
San Sebastian, Eider  
dc.contributor.author
Páez, Paulina Laura  
dc.contributor.author
Nogales, Estela  
dc.contributor.author
Esteban, Jaime  
dc.contributor.author
Gómez Ruiz, Santiago  
dc.date.available
2024-02-09T15:22:49Z  
dc.date.issued
2023-07  
dc.identifier.citation
Ugalde Arbizu, Maider; Aguilera Correa, John Jairo; San Sebastian, Eider; Páez, Paulina Laura; Nogales, Estela; et al.; Antibacterial Properties of Mesoporous Silica Nanoparticles Modified with Fluoroquinolones and Copper or Silver Species; Multidisciplinary Digital Publishing Institute; Pharmaceuticals; 16; 7; 7-2023; 1-21  
dc.identifier.uri
http://hdl.handle.net/11336/226652  
dc.description.abstract
Antibiotic resistance is a global problem and bacterial biofilms contribute to its development. In this context, this study aimed to perform the synthesis and characterization of seven materials based on silica mesoporous nanoparticles functionalized with three types of fluoroquinolones, along with Cu2+ or Ag+ species to evaluate the antibacterial properties against Staphylococcus aureus, Enterococcus faecalis, Escherichia coli, and Pseudomonas aeruginosa, including clinical and multi-drug-resistant strains of S. aureus and P. aeruginosa. In addition, in order to obtain an effective material to promote wound healing, a well-known proliferative agent, phenytoin sodium, was adsorbed onto one of the silver-functionalized materials. Furthermore, biofilm studies and the generation of reactive oxygen species (ROS) were also carried out to determine the antibacterial potential of the synthesized materials. In this sense, the Cu2+ materials showed antibacterial activity against S. aureus and E. coli, potentially due to increased ROS generation (up to 3 times), whereas the Ag+ materials exhibited a broader spectrum of activity, even inhibiting clinical strains of MRSA and P. aeruginosa. In particular, the Ag+ material with phenytoin sodium showed the ability to reduce biofilm development by up to 55% and inhibit bacterial growth in a “wound-like medium” by up to 89.33%.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Multidisciplinary Digital Publishing Institute  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by/2.5/ar/  
dc.subject
BIOFILM  
dc.subject
COPPER  
dc.subject
FLUOROQUINOLONE  
dc.subject
MSN  
dc.subject
SILVER CHLORIDE  
dc.subject.classification
Otras Nanotecnología  
dc.subject.classification
Nanotecnología  
dc.subject.classification
INGENIERÍAS Y TECNOLOGÍAS  
dc.title
Antibacterial Properties of Mesoporous Silica Nanoparticles Modified with Fluoroquinolones and Copper or Silver Species  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2024-02-09T11:06:25Z  
dc.identifier.eissn
1424-8247  
dc.journal.volume
16  
dc.journal.number
7  
dc.journal.pagination
1-21  
dc.journal.pais
Suiza  
dc.journal.ciudad
Basilea  
dc.description.fil
Fil: Ugalde Arbizu, Maider. Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz; España. Universidad del País Vasco; España. Universidad Rey Juan Carlos; España  
dc.description.fil
Fil: Aguilera Correa, John Jairo. Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz; España. Instituto de Salud Carlos III; España  
dc.description.fil
Fil: San Sebastian, Eider. Universidad del País Vasco; España  
dc.description.fil
Fil: Páez, Paulina Laura. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica; Argentina  
dc.description.fil
Fil: Nogales, Estela. Universidad Rey Juan Carlos; España  
dc.description.fil
Fil: Esteban, Jaime. Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz; España. Instituto de Salud Carlos III; España  
dc.description.fil
Fil: Gómez Ruiz, Santiago. Universidad Rey Juan Carlos; España  
dc.journal.title
Pharmaceuticals  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.3390/ph16070961  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.mdpi.com/1424-8247/16/7/961